Overview
Maarten Larmuseau is co-founder and CEO of Nuclivision, a Ghent-based healthtech company developing AI-enhanced software for nuclear imaging.
Maarten Larmuseau is co-founder and chief executive of Nuclivision, and is based in Ghent. He has led the company as CEO since January 2023, having joined it as a senior data scientist in October 2022, a role he held until February 2023.
Before that, he was a doctoral researcher at Universiteit Gent from October 2017 to October 2022. He studied at Ghent University throughout, taking a bachelor's degree in engineering physics between 2011 and 2014, followed by master's degrees in engineering physics and in biomedical engineering, both completed in 2016, and a master's degree in business engineering with a specialisation in data science in 2017.
Career history
In the news
- Beyond the booth: What our team is looking forward to at EANM 2026 💬 EANM is about more than showcasing technology. It's about connecting research with clinical practice, exchanging ideas, and having the conversations that move nuclear medicine forward. So, what is our team most looking forward to at #EANM2026? Jeremy De Sy, CCO “This year’s EANM feels different for us. NUCLARITY is now being used clinically in centers across Europe, and we’re seeing real momentum in how departments approach PET efficiency. I’m looking forward to
- Vienna bound! 🇦🇹 The booth is on its way, the team is packing their bags. And yes, our give away socks are coming. At Nuclivision, we build #NUCLARITY, AI software that helps nuclear medicine departments get high-quality PET images with shorter scans or lower injected activity. Here’s what EANM 2026 means to the people you’ll meet at our booth: Tomas Brants, COO “Four years ago, we arrived at EANM as newcomers with an idea. Since then, we’ve grown into a network of hospitals, research collaborators and partners who share our
- In less than two weeks, the game is on! ⚔️ The competition is fierce, so expect a tightly contested final 😏 Looking forward to competing with Chift API, Introw, Leexi, Maurice & Nora, Sirona Technologies, Spotable, Spott, WARREN and ZYGO. Competition aside, it is another wonderful opportunity to put nuclear medicine in the spotlight. Thanks for this opportunity 🙏 Deloitte Lidia Belevitch Anaïs De Boulle Stefanie Deronne
- As of today we have officially left the Wintercircus Ghent and moved on to Watt The Health 🎪 ➡️ 🏢 Our two years in the beating heart of Ghent have flown by, filled with warm memories and important milestones for nuclivision. We entered as what sometimes felt as a student project, and left as a company. A big thank you to Bruno Vandegehuchte, Louis Jonckheere Lorenz Bogaert, Noah Henriques da Silva and the whole team for allowing us to grow in this vibrant community. Looking forward to what the next two years will bring 🚀
- ONE HOUR TO GO: JOIN OUR WEBINAR ON ALZHEIMER’S IMAGINGWhat if an amyloid PET scan could tell us more than whether amyloid is present? Today, Prof Silvia Morbelli and Maarten Larmuseau will explore how AI-powered denoising could support dual-phase amyloid PET and what that could mean for understanding neurodegeneration and disease staging. 🔬 We’ll discuss: · AI and PET imaging · Dual-phase amyloid PET · Deep learning denoising · Clinical applications · What AI could realistically bring to practice If you work in nuclear
- One day left to register! 📣 Tomorrow at 4:30 PM CET, Prof. Silvia Morbelli (University of Turin) and our CEO Maarten Larmuseau come together for a live session on AI's role in transforming PET imaging for Alzheimer's diagnosis and care. They'll cover the clinical impact of reduced scan time in both early perfusion imaging and late-phase scanning, and what AI-powered imaging can realistically bring next. Expect a clinical perspective grounded in research and time for live Q&A. Free to attend, open to anyone working in or
- What if we could get more information from the PET scans we’re already performing? Only four days until our first webinar where Prof. Silvia Morbelli, MD discusses how better image quality could open the door to extracting more clinically relevant information from a single scan. Join us for a clinical deep-dive into how AI is transforming PET imaging in Alzheimer's disease management and explore together with Maarten Larmuseau how AI is transforming PET scanning today and what's on the horizon. 📅 Monday, September 22nd | 4:30
- On the road! 🚗 The (in)famous “European summer” has clearly ended 😅 In the past 24 hours I had the opportunity to pitch nuclivision at three different events. Let’s go 🚀🚀
Related profiles
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.